Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival is a research paper published in Journal of Cancer Research and Clinical Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
K12
Grant: P30CA016058
NIA NIH HHS
Grant: R03 AG064374
NCATS NIH HHS
Grant: UL1 TR002733
NCI NIH HHS
Grant: K12 CA133250
NIA NIH HHS
Grant: K01 AG070310
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5R03AG064374-02
Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): A Pilot Intervention Study
National Institutes of Health
Grant: 5UL1TR002733-02
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
National Institutes of Health
Grant: 2K12CA133250-16
OSU K12 Training Grant in Oncology
FWCI
2.88
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals